Asthma diagnosis in young children is one of the more difficult areas in paediatric medicine. The word "wheeze" covers a range of sounds, and not all wheezing children have asthma. Under the age of five it is genuinely hard to confirm the diagnosis, and treatment is often given as a therapeutic trial. By school age, spirometry and reversibility testing make things clearer.
What is not difficult is the importance of using inhalers correctly. The majority of asthma-related hospital admissions in children are preventable with better inhaler technique, consistent use of preventer treatment, and a clear action plan that families understand and can act on before things escalate.
Healthbooq (healthbooq.com) covers asthma management through childhood.
How Asthma Works
Asthma is a chronic inflammatory condition of the airways. In people with asthma, the airways are persistently inflamed and hyper-responsive, meaning they react to triggers more strongly than normal. When exposed to a trigger, three things happen: the muscles around the airway walls contract (bronchospasm), the lining swells, and excess mucus is produced. The result is a narrowed airway and the characteristic symptoms: wheeze, chest tightness, cough, and breathlessness.
In children, common triggers include viral respiratory infections (particularly rhinovirus), exercise, cold air, tobacco smoke, pet dander (especially cats), house dust mite, pollen, and mould. Identifying a child's personal trigger pattern is useful for management.
Preventer vs Reliever
Understanding these two categories is the foundation of asthma management.
A reliever inhaler contains a short-acting beta-2 agonist (SABA), most commonly salbutamol (blue inhaler). It relaxes the muscles around the airway within minutes and provides rapid symptom relief. It should be used when symptoms occur. Needing a reliever more than twice a week (outside of exercise) is a sign that asthma is not well-controlled.
A preventer inhaler contains an inhaled corticosteroid (ICS), most commonly beclometasone or fluticasone (typically brown, orange, or red). It works by reducing airway inflammation over time. It must be taken every day, even when the child feels completely well — this is the point parents often find counterintuitive. The benefit builds over weeks. Missing doses during a symptom-free period means the airways remain inflamed and ready to react.
NICE guidance for children's asthma (NG80) recommends starting low-dose ICS preventer therapy for children who need reliever treatment more than twice a week or who have had any asthma attack.
Spacers
A spacer is a plastic chamber that attaches to a pressurised metered-dose inhaler (pMDI). The puffed drug collects in the chamber and the child breathes it in at their own pace. This serves two purposes: it removes the need to coordinate actuation and inhalation simultaneously (which most children under eight, and many adults, cannot do reliably), and it reduces the amount of drug deposited in the mouth and throat.
Spacers improve drug delivery to the lungs by two to three times compared to an uncoordinated pMDI alone. They are not optional extras — they are essential, particularly in young children.
For children under three, use a spacer with a face mask. For older children, a spacer with a mouthpiece is preferred. Clean the spacer monthly by washing in diluted washing-up liquid and leaving to air-dry — do not wipe dry, as this creates electrostatic charge that makes drug particles stick to the walls.
Dry powder inhalers (like Turbohaler or Accuhaler) do not require a spacer but require a forceful, fast inhalation that very young children cannot reliably produce. They are generally not used under age six.
Inhaler Technique
Poor technique is the single most common reason for poorly controlled asthma. Studies consistently find that around 70 per cent of children (and adults) use their inhalers incorrectly. The most common errors with a pMDI and spacer are: not shaking the inhaler before use, firing more than one puff per breath, not holding the breath after inhalation, and breathing too fast.
At every asthma review, the nurse or GP should watch the child use their inhaler and correct technique in real time. A demonstration alone is less effective than observed practice with feedback.
Asthma Action Plans
Every child with asthma should have a written personal asthma action plan, updated at least annually. The plan describes what the child's asthma looks like when well-controlled (their "green zone"), what it looks like when symptoms are developing (amber zone), and what to do in an acute attack (red zone).
A clear plan typically tells families: how many puffs of reliever to give if symptoms begin, how many puffs to give if symptoms worsen, when to call 999, and how to manage at school. Plans can be downloaded and printed from Asthma UK (now Asthma + Lung UK), and the charity also runs a free helpline staffed by nurses.
Recognising a Serious Attack
Signs of a serious asthma attack that require emergency treatment include: reliever inhaler not working or wearing off within four hours, breathlessness preventing normal speech, very fast breathing, accessory muscle use (visible tracheal tug or subcostal recession), cyanosis (blue lips or fingertips), and agitation or reduced consciousness.
The protocol in an acute attack is: sit the child up, give 10 puffs of salbutamol via spacer (one puff per breath, in sequence), call 999 if no improvement, and continue giving salbutamol every four minutes while waiting for an ambulance.
Annual Reviews
NICE recommends annual structured asthma reviews for all children. The review should cover: symptom frequency, exercise tolerance, sleep disturbance, school absence, reliever use, preventer adherence, inhaler technique, trigger identification, action plan update, and growth (given that high-dose ICS has a small effect on growth velocity in some children, though this is largely reversible and does not affect final adult height at standard doses).
Key Takeaways
Asthma is the most common chronic condition in childhood in the UK, affecting around 1.1 million children. Management rests on understanding the difference between preventer inhalers (inhaled corticosteroids, taken daily regardless of symptoms) and reliever inhalers (short-acting beta-agonists, taken for acute symptoms). Using a spacer device with a pressurised metered-dose inhaler dramatically improves drug delivery to the lungs and is essential for all children and most adults. Every child with asthma should have a written asthma action plan reviewed annually. The majority of childhood asthma is well-controlled with low-dose preventer therapy and a reliever for breakthrough symptoms.
